Roche Holding Ltd ADR
RHO6.F
| Exchange: | F |
| Currency | Euro |
| ISIN: | US7711951043 |
| Primary Ticker: | RO.SW |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - General |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. |
| Address: | Grenzacherstrasse 124, Basel, Switzerland, 4058 |
| Website: | https://www.roche.com |
| Full Time Employees: | 103605 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 232677949440 |
| Market Capitalization Mln: | 232677.94 |
| EBITDA: | 21041000448 |
| PE Ratio: | 20.32 |
| PEG Ratio: | 1.14 |
| Wall Street Target Price: | 52.44 |
| Book Value: | 36.32 |
| Dividend Share: | 9.6 |
| Dividend Yield: | 0.03 |
| Earnings Share: | 1.75 |
| Most Recent Quarter: | 2023-06-30 |
| Profit Margin: | 0.17 |
| Operating Margin TTM: | 0.35 |
| Return On Assets TTM: | 0.12 |
| Return On Equity TTM: | 0.36 |
| Revenue TTM: | 60580999168 |
| Revenue Per Share TTM: | 9.48 |
| Gross Profit TTM: | 47828000000 |
| Diluted Eps TTM: | 1.75 |
| Quarterly Earnings Growth YOY: | -0.12 |
Valuation
| Trailing PE: | 20.32 |
| Forward PE: | 12.82 |
| Price Sales TTM: | 3.84 |
| Price Book MRQ: | 7.35 |
| Enterprise Value: | 261563517075 |
| Enterprise Value Revenue: | 4.05 |
| Enterprise Value Ebitda: | 13.88 |
Shares
| Shares Outstanding: | 5520779776 |
| Shares Float: | 727014305 |
| Percent Institutions: | 0.87 |
Technicals
| Beta: | 0.14 |
| 52 Week High: | 38.5 |
| 52 Week Low: | 27.1 |
| 50 Day MA: | 35.84 |
| 200 Day MA: | 32.45 |
Splits & Dividends
| Forward Annual Dividend Rate: | 1.3 |
| Forward Annual Dividend Yield: | 0.03 |
| Payout Ratio: | 0.75 |
| Ex Dividend Date: | 2024-03-14 |
| Last Split Factor: | 2:1 |
| Last Split Date: | 2014-02-27 |
Earnings
| Report Date: | 2025-01-30 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Report Date: | 2024-10-23 |
| Date: | 2024-09-30 |
| Before After Market: | After Market |
| Currency: | CHF |
| Date: | 2024-09-30 |